Ear-Zap therapy could spare kids from harsh kidney drugs
NCT ID NCT05583942
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a noninvasive device that gently stimulates a nerve in the ear to help children with steroid-resistant nephrotic syndrome, a kidney condition that doesn't respond to standard steroids. The goal is to see if this approach is feasible and tolerable, and if it can reduce inflammation and protein in the urine. Ten children aged 3-17 with specific kidney diagnoses will be randomly assigned to real or sham stimulation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL SEGMENTAL GLOMERULOSCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Cohen Children's Medical Center
RECRUITINGNew Hyde Park, New York, 11040, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Kidney disease mystery: scientists launch massive data hunt
- Scientists hunt for genes behind kidney disease
- New drug aims to plug kidney leaks in multiple diseases
- New pill aims to plug protein leak in kidney patients
- Could less steroid be just as good for kids with kidney disease?
- New biobank aims to unlock why kidney disease returns after transplant